4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001104659-23-001881
10% owner bought 180,703 shares at an average $7.28 ($1,314,806)
From the SEC's structured data for this filing
Trades in this filing
RA CAPITAL MANAGEMENT, L.P. · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-04 | Purchase : show line 1 in the form | +122,334 | $7.03 | $859,714 | 9,628,259 | I |
| 2023-01-04 | Purchase : show line 2 in the form | +58,369 | $7.80 | $455,091 | 9,686,628 | I |
| Open-market purchases · 180,703 sh · avg $7.28 · $1,314,806 | ||||||
Loading xslF345X03/tm232548-1_4seq1.xml…